PDGFRA-IN-1 (Compound 4p) is an inhibitor of platelet-derived growth factor receptor A (PDGFRA) with an IC50 of 1.25 µM. It exhibits notable anti-cancer properties and is effective in eliminating cancer cells, including primary glioma cells derived from patients.
Target:
PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted
